United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 01:19PM EDT. Market open.
| Previous Close | 346.19 |
| Open | 345.77 |
| Bid | 343.52 x 100 |
| Ask | 344.80 x 100 |
| Day's Range | 342.50 - 345.77 |
| 52 Week Range | 208.62 - 366.08 |
| Volume | |
| Avg. Volume | 516,666 |
| Market Cap | 15.295B |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 15.78 |
| EPS (TTM) | 21.78 |
| Earnings Date | Oct 30, 2024 - Nov 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 357.77 |
- Business Wire
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 10, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2024 Corporate Responsibility and Public Benefit Report (Report) covering its FY 2023 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of patients and other stakeholders.
FX EmpireUnited Therapeutics Shares Thrive
Revenue growth and a recent regulatory win are driving shares of United Therapeutics Corporation (UTHR) upward.
ZacksUnited Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.